According to a recent report, “The State Of Digital Excellence In The Global Pharmaceutical Industry, 2023: Clinical Operations,” by DT Consulting (Indegene is the parent company), the pharmaceutical industry’s clinical trial digital transformation digital excellence journey is marked by significant advancements and formidable challenges. This article delves into the report’s key findings and provides strategic insights for organizations striving to enhance their digital capabilities in clinical operations.

Current State of Digital Excellence

DT Consulting’s report reveals a mixed picture of digital maturity within the clinical operations of major pharmaceutical firms. While the overall digital maturity score remains stable at 57, indicating a “good” level, the lack of substantial progress since last year signals a need for renewed focus and innovation. Notably, the highest-ranked company scored nearly 90, while the lowest-ranked scored 23, illustrating the wide variability in digital capabilities across the industry.

Pharmaceutical companies are increasingly prioritizing clinical research sites, recognizing that improving the experiences of these sites and the patients they serve is critical to digital strategy success. However, internal enablement—enhancing the digital capabilities of clinical operations teams—remains a top priority for best-in-class companies.

Challenges in Digital Transformation

The report identifies several challenges that pharmaceutical firms face in sustaining digital transformation:

  1. Financial Constraints: Securing budgets for long-term digital initiatives remains a significant hurdle. Nearly half of the surveyed leaders reported budget challenges, with 69% expecting their digital transformation budgets to stay flat or decrease in the coming year. This financial strain is further compounded by the discontinuation of digital plans implemented during the COVID-19 pandemic, with 33% of leaders indicating these plans are no longer in place.
  2. Integration of New Technologies: Embedding advanced digital tools into existing clinical operations is complex, requiring not only technological adaptation but also alignment with regulatory compliance, data security, and interoperability standards. Leaders cited technology complexity as the most common challenge, underscoring the need for comprehensive strategies to integrate innovations smoothly.
  3. Resource Allocation and Skill Development: There is a notable gap in digital expertise within global clinical ops teams. While 80% of firms actively recruit digital experts, less than half provide adequate training resources for current and new employees, highlighting a critical area for improvement.

Key Insights and Recommendations

Despite these challenges, there are clear paths forward for organizations aiming to achieve digital excellence in clinical trials. Here are some strategic recommendations based on the report’s findings:

  1. Prioritize Data-Driven Decision-Making: Leveraging data to drive clinical trial strategies is crucial. In 2023, 83% of senior leaders reported having a defined vision and strategy for digital transformation, up from 75% in 2022. Organizations should improve data capture and analytics capabilities to enhance decision-making processes and patient outcomes.
  2. Balance Quick Wins with Long-Term Goals: Conduct a comprehensive audit of ongoing projects to identify opportunities for quick wins that align with long-term digital objectives. This approach helps secure funding and demonstrates immediate value while progressing towards broader transformation goals. For instance, site selection, feasibility, and site startup have shown significant maturity increases, making them prime areas for achieving quick wins.
  3. Set Smart KPIs: Defining clear, measurable key performance indicators (KPIs) is essential for tracking the impact of digital initiatives. Engaging stakeholders to define these KPIs collaboratively ensures they align with the evolving landscape of clinical trial innovation. The report highlights that a lack of well-defined KPIs impedes leaders’ ability to gauge digital strategy effectiveness.
  4. Enhance Cross-Functional Collaboration: Foster open communication and idea exchange across different organizational functions. Regular cross-functional workshops and the use of shared digital platforms can facilitate the seamless integration of digital strategies. The report notes that organizations with higher digital maturity scores often demonstrate better cross-functional collaboration.
  5. Invest in Local Talent and Resources: Address skill gaps by allocating resources for targeted training programs and establishing local digital innovation hubs. Investing in local talent ensures teams are well-equipped to tackle digital challenges and contribute to successful project execution. Nearly half of clinical ops leaders noted that more than 10% of their global team members have specific expertise in clinical trial digital capabilities, indicating progress but also room for improvement.

Summary

The journey towards digital excellence in clinical trials is complex but essential. By addressing financial constraints, integrating new technologies, and investing in digital skills, pharmaceutical companies can overcome current challenges and unlock the full potential of digital transformation. As the industry evolves, embracing data-driven strategies, balancing immediate wins with long-term goals, and fostering collaboration will be key to achieving digital excellence in clinical operations.

For more insights and detailed recommendations, refer to DT Consulting’s comprehensive report on digital excellence in the pharmaceutical industry.

Moe Alsumidaie
Website | + posts

Moe Alsumidaie is Chief Editor of The Clinical Trial Vanguard. Moe holds decades of experience in the clinical trials industry. Moe also serves as Head of Research at CliniBiz and Chief Data Scientist at Annex Clinical Corporation.